Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$109,293
+$32,726 QoQ
Shares Held
13,152
+20.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#137
of 198 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names. ARVN ranks #16 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,452 | $3,701,631 | |
| 2 | INCY |
Incyte Corp
|
23,563 | $2,671,101 | |
| 3 | INSM |
INSMED Inc
|
16,847 | $1,796,227 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,073 | $1,086,350 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
2,390 | $585,000 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
24,477 | $356,629 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
22,841 | $350,837 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
5,218 | $314,958 |
All Filings in ARVN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,293 | 13,152 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $76,567 | 10,907 | Shares | Sole | 2025-05-12 | |
| 2024-06-30 | $318,614 | 11,969 | Shares | Sole | 2024-08-09 | |
| 2021-09-30 | $312,694 | 3,805 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $533,785 | 6,285 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,165,106 | 49,348 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,293,268 | 38,559 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $286,976 | 7,121 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||